243 related articles for article (PubMed ID: 37522278)
21. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
Jemimah S; AlShehhi A;
BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
[TBL] [Abstract][Full Text] [Related]
22. Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration.
Taylor A; Zhang F; Niu X; Heywood A; Stocks J; Feng G; Popuri K; Beg MF; Wang L;
Neuroimage; 2022 Nov; 263():119621. PubMed ID: 36089183
[TBL] [Abstract][Full Text] [Related]
23. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
[TBL] [Abstract][Full Text] [Related]
24. Transferability of Alzheimer's disease progression subtypes to an independent population cohort.
Chen H; Young A; Oxtoby NP; Barkhof F; Alexander DC; Altmann A;
Neuroimage; 2023 May; 271():120005. PubMed ID: 36907283
[TBL] [Abstract][Full Text] [Related]
25. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
[TBL] [Abstract][Full Text] [Related]
26. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
27. A hybrid multimodal machine learning model for Detecting Alzheimer's disease.
Sheng J; Zhang Q; Zhang Q; Wang L; Yang Z; Xin Y; Wang B
Comput Biol Med; 2024 Mar; 170():108035. PubMed ID: 38325214
[TBL] [Abstract][Full Text] [Related]
28. Decoding the heterogeneity of Alzheimer's disease diagnosis and progression using multilayer networks.
Avelar-Pereira B; Belloy ME; O'Hara R; Hosseini SMH;
Mol Psychiatry; 2023 Jun; 28(6):2423-2432. PubMed ID: 36539525
[TBL] [Abstract][Full Text] [Related]
29. Ensemble of convolutional neural networks and multilayer perceptron for the diagnosis of mild cognitive impairment and Alzheimer's disease.
Li M; Jiang Y; Li X; Yin S; Luo H
Med Phys; 2023 Jan; 50(1):209-225. PubMed ID: 36121183
[TBL] [Abstract][Full Text] [Related]
30. Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.
Petrella JR; Hao W; Rao A; Doraiswamy PM
Comput Math Methods Med; 2019; 2019():6216530. PubMed ID: 30863455
[TBL] [Abstract][Full Text] [Related]
31. Imaging plus X: multimodal models of neurodegenerative disease.
Oxtoby NP; Alexander DC;
Curr Opin Neurol; 2017 Aug; 30(4):371-379. PubMed ID: 28520598
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
Dong A; Toledo JB; Honnorat N; Doshi J; Varol E; Sotiras A; Wolk D; Trojanowski JQ; Davatzikos C;
Brain; 2017 Mar; 140(3):735-747. PubMed ID: 28003242
[TBL] [Abstract][Full Text] [Related]
33. [Research on classification method of multimodal magnetic resonance images of Alzheimer's disease based on generalized convolutional neural networks].
Qin Z; Liu Z; Lu Y; Zhu P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Apr; 40(2):217-225. PubMed ID: 37139751
[TBL] [Abstract][Full Text] [Related]
34. DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders.
Marinescu RV; Eshaghi A; Lorenzi M; Young AL; Oxtoby NP; Garbarino S; Crutch SJ; Alexander DC;
Neuroimage; 2019 May; 192():166-177. PubMed ID: 30844504
[TBL] [Abstract][Full Text] [Related]
35. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
[TBL] [Abstract][Full Text] [Related]
36. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
[TBL] [Abstract][Full Text] [Related]
37. [Alzheimer's disease classification based on nonlinear high-order features and hypergraph convolutional neural network].
Zeng A; Luo B; Pan D; Rong H; Cao J; Zhang X; Lin J; Yang Y; Liu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Oct; 40(5):852-858. PubMed ID: 37879913
[TBL] [Abstract][Full Text] [Related]
38. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
[TBL] [Abstract][Full Text] [Related]
39. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
40. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
